Trial
NCT03059888
Trial of Orencia in Patients With Myasthenia Gravis
Early Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Johns Hopkins University
Collaborators
Bristol-Myers Squibb
Condition
Myasthenia Gravis
Intervention
Abatacept Injection
Why stopped
Mutual decision of sponsor and investigator due to logistical challenges
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-11-22